Biotech And CDMOs: Overcoming Drug Development Challenges
In today’s fast-paced market, biotech firms continue to encounter many hurdles, especially during the clinical phase of drug development. Biologics may pose significant technical and commercial risks due to their exorbitant prices, intricate production …